168 related articles for article (PubMed ID: 23996340)
1. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.
Park JH; Baek EK; Choi CH; Lee KH; Kim BJ; Kim JW; Kim JG; Chang SK
Surg Endosc; 2014 Jan; 28(1):235-41. PubMed ID: 23996340
[TBL] [Abstract][Full Text] [Related]
2. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
Imaeda H; Hosoe N; Suzuki H; Saito Y; Ida Y; Nakamura R; Iwao Y; Ogata H; Hibi T
J Gastroenterol; 2011 Nov; 46(11):1267-72. PubMed ID: 21805066
[TBL] [Abstract][Full Text] [Related]
3. The effect of sequential therapy with lansoprazole and ecabet sodium in treating iatrogenic gastric ulcer after endoscopic submucosal dissection: a randomized prospective study.
Ahn JY; Choi CH; Lee JW; Park SJ; Kim JW; Chang SK; Han SB
J Dig Dis; 2015 Feb; 16(2):75-82. PubMed ID: 25420889
[TBL] [Abstract][Full Text] [Related]
4. Optimal duration of proton pump inhibitor in the treatment of endoscopic submucosal dissection-induced ulcers: a retrospective analysis and prospective validation study.
Lee SH; Lee CK; Chung IK; Shim YS; Lee TH; Lee SH; Kim HS; Park SH; Kim SJ
Dig Dis Sci; 2012 Feb; 57(2):429-34. PubMed ID: 22001942
[TBL] [Abstract][Full Text] [Related]
5. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
Hirai A; Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Tominaga K; Tokioka S; Higuchi K
Dig Dis Sci; 2018 Apr; 63(4):974-981. PubMed ID: 29464587
[TBL] [Abstract][Full Text] [Related]
7. The effect of short-term proton pump inhibitor plus anti-ulcer drug on the healing of endoscopic submucosal dissection-derived artificial ulcer: a randomized controlled trial.
Nakamura M; Tahara T; Shiroeda H; Matsunaga K; Otsuka T; Yonemura J; Shibata T; Arisawa T
Hepatogastroenterology; 2015; 62(137):219-24. PubMed ID: 25911899
[TBL] [Abstract][Full Text] [Related]
8. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
[TBL] [Abstract][Full Text] [Related]
9. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
Horikawa Y; Mizutamari H; Mimori N; Kato Y; Fushimi S; Sato S; Okubo S
Scand J Gastroenterol; 2018 Feb; 53(2):243-251. PubMed ID: 29214885
[TBL] [Abstract][Full Text] [Related]
10. Comparison of oral and intravenous lansoprazole for the prevention of bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: a prospective randomized phase II study (KDOG 0802).
Ishido K; Tanabe S; Azuma M; Katada C; Wada T; Yano T; Koizumi W
Surg Endosc; 2018 Jun; 32(6):2939-2947. PubMed ID: 29273872
[TBL] [Abstract][Full Text] [Related]
11. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
[TBL] [Abstract][Full Text] [Related]
12. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers.
Takayama M; Matsui S; Kawasaki M; Asakuma Y; Sakurai T; Kashida H; Kudo M
World J Gastroenterol; 2013 Sep; 19(34):5706-12. PubMed ID: 24039365
[TBL] [Abstract][Full Text] [Related]
14. Two-week treatment with proton pump inhibitor is sufficient for healing post endoscopic submucosal dissection ulcers.
Arai M; Matsumura T; Okimoto K; Oyamada A; Saito K; Minemura S; Maruoka D; Tanaka T; Nakagawa T; Katsuno T; Yokosuka O
World J Gastroenterol; 2014 Nov; 20(43):16318-22. PubMed ID: 25473190
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter, Randomized, Controlled Trial of Rebamipide Plus Lansoprazole for the Treatment of Postendoscopic Submucosal Dissection Ulcers.
Yan B; Lu Z; Ge Z; Liu S; Guo X; Tian D; Yang Y; Li X; Gong W; Liu Z; Liu M; Zhou B; Zhao K; Pan F; Yang J; Yang Y
Clin Transl Gastroenterol; 2019 Jan; 10(1):e00008. PubMed ID: 30702488
[TBL] [Abstract][Full Text] [Related]
16. Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy.
Nakamura K; Ihara E; Akiho H; Akahoshi K; Harada N; Ochiai T; Nakamura N; Ogino H; Iwasa T; Aso A; Iboshi Y; Takayanagi R
Gut Liver; 2016 Nov; 10(6):917-924. PubMed ID: 27282261
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
Kawano S; Okada H; Kawahara Y; Hori K; Tanioka D; Tsuzuki T; Inoue M; Yagi S; Takenaka R; Yamamoto K
Digestion; 2011; 84(1):46-53. PubMed ID: 21304241
[TBL] [Abstract][Full Text] [Related]
19. Basal protrusion of ulcers induced by endoscopic submucosal dissection (ESD) during treatment with proton pump inhibitors, and the suppressive effects of polaprezinc.
Inaba T; Ishikawa S; Toyokawa T; Ishikawa H; Miyahara K; Wato M; Kawai K; Okada H; Yamamoto K
Hepatogastroenterology; 2010; 57(99-100):678-84. PubMed ID: 20698249
[TBL] [Abstract][Full Text] [Related]
20. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]